VirnetX CEO sells 14,575 shares under plan

Rhea-AI Filing Summary

VirnetX Holding Corp (VHC) reports that its President & CEO and ten percent owner, Kendall Larsen, sold a total of 14,575 shares of common stock in open-market transactions on August 31, 2026, September 1, 2026, and September 2, 2026, under a Rule 10b5-1 trading plan adopted on May 29, 2026. Indirect holdings reported as of August 31, 2026, include 74,649 shares held by a spouse, 30,676 shares held by the Kathleen Sheehan Revocable Trust, and 15,000 shares held by The K2 Investment Fund LLC.

Insider Trade Summary 10b5-1

Net Seller: 14,575 shares

Net Sell 7 txns

Insider Larsen Kendall

Role President & CEO

Sold 14,575 shs ($163K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F4	4,057	$11.426	$46K
Sale	Common Stock F1, F5	518	$12.132	$6K
Sale	Common Stock F1, F3	5,000	$11.001	$55K
Sale	Common Stock F1, F2	5,000	$11.168	$56K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 360,058 shares (Direct); Common Stock — 74,649 shares (Indirect, By: Spouse); Common Stock — 30,676 shares (Indirect, By: The Kathleen Sheehan Revocable Trust dtd 2/5/2009); Common Stock — 15,000 shares (Indirect, By: The K2 Investment Fund LLC)

Footnotes (5)

1. F1. The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 29, 2026.
2. F2. This sale price represents the weighted average sale price of the shares sold ranging from $11.00 to $11.63 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
3. F3. This sale price represents the weighted average sale price of the shares sold ranging from $10.63 to $11.545 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
4. F4. This sale price represents the weighted average sale price of the shares sold ranging from $10.96 to $11.89 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
5. F5. This sale price represents the weighted average sale price of the shares sold ranging from $12.12 to $12.15 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Key Figures

Total shares sold: 14,575 shares Sale on August 31, 2026 (first block): 5,000 shares at $11.17 weighted average Sale on September 1, 2026: 5,000 shares at $11.00 weighted average +5 more

8 metrics

Total shares sold 14,575 shares Open-market sales of VirnetX common stock reported for August 31 to September 2, 2026

Sale on August 31, 2026 (first block) 5,000 shares at $11.17 weighted average Weighted average price with a range of $11.00 to $11.63 per share

Sale on September 1, 2026 5,000 shares at $11.00 weighted average Weighted average price with a range of $10.63 to $11.545 per share

Sale on September 2, 2026 (4,057-share block) 4,057 shares at $11.43 weighted average Weighted average price with a range of $10.96 to $11.89 per share

Sale on September 2, 2026 (518-share block) 518 shares at $12.13 weighted average Weighted average price with a range of $12.12 to $12.15 per share

Indirect holdings by spouse 74,649 shares Indirect beneficial ownership reported as of August 31, 2026, held by spouse

Indirect holdings by Kathleen Sheehan Revocable Trust 30,676 shares Indirect beneficial ownership reported as of August 31, 2026, held by revocable trust

Indirect holdings by The K2 Investment Fund LLC 15,000 shares Indirect beneficial ownership reported as of August 31, 2026, held by investment fund

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, Revocable Trust, investment fund

4 terms

Rule 10b5-1 trading plan regulatory

"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 29, 2026."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"This sale price represents the weighted average sale price of the shares sold ranging from $11.00 to $11.63 per share."

Revocable Trust financial

"By: The Kathleen Sheehan Revocable Trust dtd 2/5/2009"

A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.

investment fund financial

"By: The K2 Investment Fund LLC"

FAQ

What insider trading activity did VirnetX (VHC) report for Kendall Larsen?

VirnetX reported that President & CEO and ten percent owner Kendall Larsen sold 14,575 shares of common stock in a series of open-market transactions on August 31, 2026, September 1, 2026, and September 2, 2026, according to the Form 4 filing.

At what prices did Kendall Larsen sell VirnetX (VHC) shares?

The reported weighted average sale prices were $11.17 (range $11.00–$11.63), $11.00 (range $10.63–$11.545), $11.43 (range $10.96–$11.89), and $12.13 (range $12.12–$12.15) per share, with full breakdowns available upon request as stated in the filing footnotes.

Were the recent VirnetX (VHC) insider sales made under a Rule 10b5-1 plan?

Yes. The filing states that the sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 29, 2026, indicating the transactions were pre-arranged under that plan.

How many VirnetX (VHC) shares does Kendall Larsen hold indirectly after these transactions?

As of August 31, 2026, indirect holdings reported are 74,649 shares held by a spouse, 30,676 shares held by the Kathleen Sheehan Revocable Trust, and 15,000 shares held by The K2 Investment Fund LLC.

What total number of VirnetX (VHC) shares did Kendall Larsen sell in each reported trade?

The Form 4 reports sales of 5,000 shares and 5,000 shares on August 31, 2026, 5,000 shares on September 1, 2026, and 4,057 shares plus 518 shares on September 2, 2026, totaling 14,575 shares sold.

What roles does Kendall Larsen hold at VirnetX (VHC) according to the Form 4?

The reporting person, Kendall Larsen, is identified as a director, the company’s President & CEO, and a ten percent owner of VirnetX Holding Corp in the Form 4 filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 07:41 PM Accepted by SEC EDGAR 09/02/2026 - 07:41 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Larsen Kendall

(Last) (First) (Middle)

C/O 308 DORLA COURT

(Street)

ZEPHYR COVE NEVADA 89448

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VirnetX Holding Corp [ VHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/31/2026		S(1)		5,000	D	$11.168(2)	369,633	D
Common Stock	09/01/2026		S(1)		5,000	D	$11.001(3)	364,633	D
Common Stock	09/02/2026		S(1)		4,057	D	$11.426(4)	360,576	D
Common Stock	09/02/2026		S(1)		518	D	$12.132(5)	360,058	D
Common Stock								74,649	I	By: Spouse
Common Stock								30,676	I	By: The Kathleen Sheehan Revocable Trust dtd 2/5/2009
Common Stock								15,000	I	By: The K2 Investment Fund LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 29, 2026.

2. This sale price represents the weighted average sale price of the shares sold ranging from $11.00 to $11.63 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

3. This sale price represents the weighted average sale price of the shares sold ranging from $10.63 to $11.545 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

4. This sale price represents the weighted average sale price of the shares sold ranging from $10.96 to $11.89 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

5. This sale price represents the weighted average sale price of the shares sold ranging from $12.12 to $12.15 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

	/s/ Kendall Larsen	09/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)